Vir Biotechnology Inc. (VIR) Tops Q4 EPS by 11c
Tweet
Share
E-mail
Get Alerts VIR Hot Sheet
Join SI Premium – FREE
Vir Biotechnology Inc. (NASDAQ: VIR) reported Q4 EPS of ($0.76), $0.11 better than the analyst estimate of ($0.87). Revenue for the quarter came in at $12.37 million versus the consensus estimate of $8.14 million.
For earnings history and earnings-related data on Vir Biotechnology Inc. (VIR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- FDA launches Operation TrialBlazer to accelerate drug research
- SpaceX signs compute deal with Reflection - CNBC
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
